The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conference
Belite Bio, Inc - American Depositary Shares (BLTE)
Company Research
Source: GlobeNewswire
NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Healthcare House Call VIRTUAL One-on-One Investor Conference happening on Tuesday & Wednesday, May 21st - 22nd, 2024. The conference offers our clients one-on-one and small group virtual meetings with the management of over 30 small and mid-sized healthcare companies. “We are pleased to once again be able to host a virtual conference with over 30 dynamic growth healthcare companies, many of which are in our research coverage universe. We have found that hosting this event virtually allows for greater scheduling flexibility for both companies and investor clients participating,” said Benchmark President Richard Messina, adding, “This year, we are excited to announce that we are extending the conference to encompass 2 days and have added a select number of fireside chats. We hope you can participate.” The Benchmark Company will be hosting: Healthcare House Call VIRTUAL One-o
Show less
Read more
Impact Snapshot
Event Time:
BLTE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLTE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLTE alerts
High impacting Belite Bio, Inc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BLTE
News
- Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $57.00 price target on the stock.MarketBeat
- Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $59.00 price target on the stock.MarketBeat
- Belite Bio, Inc (NASDAQ: BLTE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor ConferenceGlobeNewswire
- Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
BLTE
Earnings
- 5/13/24 - Beat
BLTE
Sec Filings
- 5/17/24 - Form 144
- 5/16/24 - Form 144
- 5/14/24 - Form 6-K
- BLTE's page on the SEC website